Reactions Weekly

, Volume 1695, Issue 1, pp 81–81 | Cite as

Brentuximab vedotin/nivolumab

Chronic liver graft versus host disease and severe infusion reaction: case report
Case report


  1. Braun M, et al. Successful management of treatment-emergent chronic graft-versus-host disease of the liver following nivolumab for relapsed hodgkin's lymphoma after allogeneic stem cell transplant. Blood 130 (Suppl. 1): no pagination, Dec 2017 [abstract] - USAGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations